Authors |
Country |
Sex |
Age at baseline (year) |
Follow-up (year) |
N |
n |
Type 2 diabetes assessment |
Coffee exposure (cups/day) |
RR (95% CI) |
Confounding adjustments |
NOS (0–9 points) |
van Dam and Feskens 2002 (3) |
Europe |
Both |
30–60 |
1–13 |
17,111 |
306 |
Self-reported |
Total coffee |
|
Educational level, leisure time physical activity, occupational physical activity, alcohol consumption, cigarette smoking, history of cardiovascular disease, known hypertension, and known hypercholesterolemia |
6 |
≤2 |
1.00 (1.00–1.00) |
3–4 |
0.79 (0.57–1.10) |
5–6 |
0.73 (0.53–1.01) |
≥7 |
0.50 (0.35–0.72) |
Reunanen et al. 2003 (11) |
Europe |
Both |
20–98 |
304,227a |
19,518 |
855 |
Confirmed cases |
Total coffee |
|
Age, sex, BMI, smoking, and leisure time physical activity |
8 |
≤2 |
1.00 (1.00–1.00) |
3–4 |
1.01 (0.81–1.27) |
5–6 |
0.98 (0.79–1.21) |
≥7 |
0.92 (0.73–1.16) |
Carlsson et al. 2004 (7) |
Europe |
Both |
30–60 |
20 |
10,652 |
408 |
Confirmed cases |
Total coffee |
|
Age, sex, BMI, education, leisure time physical activity, alcohol consumption, and smoking |
6 |
≤2 |
1.00 (1.00–1.00) |
3–4 |
0.70 (0.48–1.01) |
5–6 |
0.71 (0.50–1.01) |
≥7 |
0.65 (0.44–0.96) |
Rosengren et al. 2004 (27) |
Europe |
F |
39–65 |
18 |
1,361 |
74 |
Confirmed cases |
Total coffee |
|
Age, smoking, low physical activity, education, BMI, and serum cholesterol and triglycerides |
8 |
≤2 |
1.00 (1.00–1.00) |
3–4 |
0.56 (0.32–0.98) |
5–6 |
0.45 (0.23–0.90) |
>6 |
0.57 (0.26–1.29) |
Salazar-Martinez et al. 2004 (4) |
U.S. |
Both |
M 40–75 |
M 12 |
41,934 |
1,333 |
Confirmed self-report |
Caffeine (men)b |
|
Age; total caloric intake; family history of diabetes; alcohol consumption; smoking status; menopausal status and postmenopausal hormone use; intakes of glycemic load, trans fat, polyunsaturated fatty acid, cereal fiber, and magnesium; BMI; and physical activity |
6 |
F 30–55 |
F 18 |
13 |
1.00 (1.00–1.00) |
74 |
1.06 (0.89–1.26) |
172 |
1. 01 (0.85–1.20) |
323 |
0.94 (0.78–1.12) |
566 |
0.80 (0.66–0.97) |
M 84,276 |
Caffeine (women)b |
|
F 4,085 |
69 |
1.00 (1.00–1.00) |
193 |
1.02 (0.93–1.11) |
328 |
0.90 (0.82–0.99) |
432 |
0.85 (0.77–0.94) |
708 |
0.70 (0.63–0.79) |
van Dam et al. 2004 (28) |
Europe |
Both |
50–74 |
6.4 |
1,312 |
128 |
OGTT |
Total coffee |
|
Age; sex; BMI; waist-hip ratio; physical activity; alcohol consumption; cigarette smoking; history of cardiovascular disease; use of antihypertensive medication; and intake of fiber, total energy, saturated fat, and polyunsaturated fat |
8 |
≤2 |
1.00 (1.00–1.00) |
3–4 |
0.94 (0.56–1.55) |
5–6 |
0.92 (0.53–1.61) |
≥7 |
0.69 (0.31–1.51) |
Greenberg et al. 2005 (35) |
U.S. |
Both |
32–88 |
8.4 |
7,006 |
170 |
Self-reported |
Caffeinated coffee |
|
Per capita income, educational level, race, sex, physical activity, smoking status, alcohol consumption, BMI, age, and type of diet; variables for consumption of caffeine and all three beverages were in the regression model simultaneously |
6 |
0 |
1.00 (1.00–1.00) |
<2 |
0.82 (0.55–1.23) |
24 |
0.75 (0.50–1.13) |
≥4 |
0.37 (0.22–0.64) |
Decaf. coffee |
|
0 |
1.00 (1.00–1.00) |
<2 |
0.62 (0.34–1.11) |
2–4 |
0.43 (0.20–0.93) |
Caffeineb |
|
75 |
1.00 (1.00–1.00) |
225 |
0.69 (0.42–1.11) |
375 |
0.73 (0.38–1.41) |
525 |
0.65 (0.30–1.42) |
750 |
0.65 (0.24–1.77) |
Iso et al. 2006 (9) |
Asia |
Both |
40–65 |
5 |
17,413 |
444 |
Self-reported |
Total coffee |
|
Family history of diabetes, smoking status, alcohol intake, magnesium intake, hours of walking, hours of exercise, and consumption of other beverages |
6 |
<2 |
0.82 (0.55–1.23) |
2–4 |
0.75 (0.50–1.13) |
≥4 |
0.37 (0.22–0.64) |
≥3 |
0.58 (0.37–0.90) |
Caffeineb |
|
57 |
1.00 (1.00–1.00) |
137 |
1.00 (0.73–1.37) |
199 |
0.98 (0.73–1.33) |
273 |
1.00 (0.74–1.37) |
416 |
0.67 (0.47–0.95) |
Paynter et al. 2006 (29) |
U.S. |
Both |
45–64 |
9 |
12,204 |
1,437 |
Self-reported |
Total coffee (men) |
|
Age, race, education, family history of diabetes, BMI, waisthip ratio, total caloric intake, dietary fiber, smoking, alcohol consumption, leisure activity, and hypertension |
8 |
0 |
1.00 (1.00–1.00) |
<1 |
1.02 (0.76–1.38) |
1 |
1.01 (0.76–1.34) |
2–3 |
0.93 (0.70–1.22) |
≥4 |
0.69 (0.50–0.96) |
Total coffee (women) |
|
0 |
1.00 (1.00–1.00) |
<1 |
1.23 (0.93–1.62) |
1 |
1.06 (0.83–1.36) |
2–3 |
0.89 (0.68–1.16) |
≥4 |
0.66 (0.45–0.96) |
Pereira et al. 2006 (13) |
U.S. |
F |
Mean 61 |
11 |
28,812 |
1,418 |
Self-reported |
Total coffee |
|
Age, education, baseline hypertension, alcohol, smoking status, cigarette pack-years, BMI, waist-hip ratio, physical activity, energy intake, total fat, Keys score, cereal fiber, tea consumption, and soda consumption |
6 |
0 |
1.00 (1.00–1.00) |
<1 |
0.95 (0.77–1.18) |
1–3 |
1.01 (0.85–1.19) |
4–5 |
0.85 (0.69–1.04) |
≥6 |
0.79 (0.61–1.02) |
Caffeinated coffee |
|
0 |
1.00 (1.00–1.00) |
<1 |
0.92 (0.76–1.11) |
1–3 |
0.88 (0.70–1.12) |
4–5 |
0.89 (0.64–1.23) |
≥6 |
1.00 (0.84–1.19) |
Decaf. coffee |
|
0 |
1.00 (1.00–1.00) |
<1 |
0.98 (0.83–1.16) |
1–3 |
1.01 (0.84–1.21) |
4–5 |
0.59 (0.44–0.80) |
≥6 |
0.68 (0.43–1.09) |
van Dam et al. 2006 (5) |
U.S. |
F |
26–46 |
20 |
88,259 |
1,263 |
Self-reported |
Total coffee |
|
Age; smoking status; BMI; physical activity; alcohol consumption; use of hormone replacement therapy; oral contraceptive use; family history of type 2 diabetes; history of hypertension; history of hypercholesterolemia; consumption of sugarsweetened soft drinks; consumption of punch; and quintiles of processed meat consumption, the polyunsaturated-tosaturated fat intake ratio, total energy intake, the glycemic index, and cereal fiber intake |
5 |
0 |
1.00 (1.00–1.00) |
<1 |
0.93 (0.80–1.09) |
1 |
0.87 (0.73–1.03) |
2–3 |
0.58 (0.49–0.68) |
≥4 |
0.53 (0.41–0.68) |
Caffeinated coffee |
|
0 |
1.00 (1.00–1.00) |
<1 |
1.00 (0.86–1.17) |
1 |
0.89 (0.75–1.07) |
2–3 |
0.62 (0.52–0.74) |
≥4 |
0.61 (0.46–0.81) |
Decaf. coffee |
|
0 |
1.00 (1.00–1.00) |
<1 |
0.86 (0.74–0.99) |
1 |
0.87 (0.68–1.11) |
2–3 |
0.52 (0.36–0.74) |
Caffeineb |
|
22 |
1.00 (1.00–1.00) |
93 |
0.88 (0.75–1.04) |
180 |
0.89 (0.75–1.05) |
341 |
0.74 (0.62–0.89) |
528 |
0.55 (0.45–0.67) |
Smith et al. 2006 (30) |
U.S. |
Both |
≥50 |
8 |
910 |
84 |
OGTT |
Total coffee |
|
Sex, age, physical activity, BMI, smoking, alcohol, hypertension, and baseline fasting plasma glucose |
7 |
0 |
1.00 (1.00–1.00) |
1–2 |
0.66 (0.38–1.14) |
3–4 |
0.53 (0.26–1.08) |
≥5 |
0.60 (0.26–1.40) |
Adeney et al. 2007 (24) |
U.S. |
F |
Mean 31 |
10 mo |
1,744 |
75 |
OGTT |
Caffeinated coffee |
|
Maternal age, smoking during pregnancy, regular alcohol use before pregnancy, maternal race, prepregnancy BMI, chronic hypertension, and average daily caloric intake |
6 |
None |
1.00 (1.00–1.00) |
Moderate |
0.58 (0.33–1.02) |
High |
0.76 (0.40–1.46) |
Fuhrman et al. 2009 (31) |
U.S. |
M |
35–79 |
2.6 |
4,685 |
519 |
OGTT |
Total coffeec |
|
Age, BMI, smoking status, family history of diabetes, education, alcohol intake, index of physical activity, and milk and sugar intake |
7 |
1–2 |
1.00 (1.00–1.00) |
3 |
0.79 (0.69–1.00) |
≥4 |
0.75 (0.58–0.97) |
Hamer et al. 2008 (32) |
Europe |
Both |
35–55 |
11.7 |
5,823 |
387 |
OGTT |
Total coffee |
|
Five-year age categories, sex, ethnicity, employment grade, plus BMI category, waist-hip ratio, smoking, sex-specific alcohol intake tertiles, physical activity category, family history of diabetes, hypertension, cholesterol, total energy intake, diet pattern, and mutual adjustment for all beverage type |
8 |
0 |
1.00 (1.00–1.00) |
≤1 |
0.83 (0.60–1.14) |
2–3 |
0.85 (0.60–1.20) |
>3 |
0.80 (0.54–1.18) |
Decaf. coffee |
|
0 |
1.00 (1.00–1.00) |
≤1 |
1.13 (0.87–1.47) |
2–3 |
0.87 (0.58–1.30) |
; |
>3 |
0.65 (0.36–1.16) |
Odegaard et al. 2008 (33) |
Asia |
Both |
45–74 |
5.7 |
36,908 |
1,889 |
Confirmed self-report |
Total coffee |
|
Age at recruitment, year of interview, sex, dialect, education, hypertension, smoking status, alcohol consumption, BMI, physical activity, dietary variables, and magnesium |
9 |
<1 |
1.00 (1.00–1.00) |
1 |
0.94 (0.81–1.09) |
2–3 |
0.83 (0.68–1.01) |
≥4 |
0.70 (0.53–0.93) |
Bidel et al. 2008 (17) |
Europe |
Both |
35–74 |
5–20 |
21,826 |
862 |
Confirmed cases |
Total coffee |
|
Age, BMI, alcohol consumption, smoking, physical activity, and glucose tolerance test |
7 |
0–2 |
1.00 (1.00–1.00) |
3–4 |
0.85 (0.70–1.04) |
5–6 |
0.78 (0.65–0.95) |
≥7 |
0.64 (0.51–0.80) |
Kato et al. 2009 (34) |
Asia |
Both |
40–69 |
10 |
55,826 |
2,694 |
Confirmed self-report |
Total coffee (men) |
|
Age, BMI, smoking status, alcohol drinking, family history of diabetes, physical activity, history of hypertension, perceived mental stress, levels of type A behavior, and hours of sleep |
8 |
0 |
1.00 (1.00–1.00) |
1–2d |
0.93 (0.80–1.08) |
3–4d |
0.84 (0.71–1.01) |
1–2 |
0.84 (0.73–0.97) |
3–4 |
0.83 (0.68–1.02) |
≥5 |
0.82 (0.60–1.11) |
Total coffee (women) |
|
0 |
1.00 (1.00–1.00) |
1–2d |
0.90 (0.76–1.06) |
3–4d |
0.95 (0.77–1.17) |
1–2 |
0.81 (0.69–0.96) |
3–4 |
0.62 (0.45–0.84) |
≥5 |
0.40 (0.20–0.78) |
Oba et al. 2010 (10) |
Asia |
Both |
<70 |
10 |
13,540 |
453 |
Self-reported |
Caffeinated coffee (men) |
|
Age, smoking status, BMI, physical activity, length of education in years, alcohol consumption, total energy intake, fat intake, and women's menopausal status to examine beverage and chocolate snacks |
6 |
0 |
1.00 (1.00–1.00) |
1/mo to 6/wk |
0.69 (0.50–0.97) |
≥1 |
0.69 (0.49–0.98) |
Caffeinated coffee (women) |
|
0 |
1.00 (1.00–1.00) |
1/mo to 6/wk |
1.08 (0.74–1.60) |
≥1 |
0.70 (0.44–1.12) |
Decaf. coffee (men) |
|
0 |
1.00 (1.00–1.00) |
≥1e |
1.09 (0.73–1.61) |
Decaf. coffee (women) |
|
0 |
1.00 (1.00–1.00) |
≥1e |
0.66 (0.36–1.23) |
Caffeine (men)b |
|
42 |
1.00 (1.00–1.00) |
79 |
0.81 (0.60–1.10) |
218 |
0.95 (0.69–1.30) |
Caffeine (women)b |
|
60 |
1.00 (1.00–1.00) |
97 |
1.26 (0.88–1.82) |
226 |
0.95 (0.63–1.43) |
Zhang et al. 2011 (23) |
U.S. |
Both |
45–74 |
7.6 |
1,141 |
188 |
OGTT |
Total coffee |
|
Age, sex, smoking, alcohol use, family history of diabetes, physical activity, and BMI |
7 |
0 |
1.00 (1.00–1.00) |
1–2 |
0.93 (0.55–1.57) |
3–4 |
0.87 (0.53–1.44) |
5–7 |
0.72 (0.43–1.23) |
8–11 |
0.78 (0.44–1.37) |
≥12 |
0.33 (0.13–0.81) |
van Dieren et al. 2009 (22) |
Europe |
Both |
49–70 |
10 |
40,011 |
918 |
Confirmed self-report |
Total coffee |
|
Cohort, sex, age, BMI, highest education, physical activity, family history of diabetes, smoking, alcohol intake, energy intake, energy-adjusted saturated fat intake, energy-adjusted fiber intake, energyadjusted vitamin C intake, hypercholesterolemia, and hypertension |
6 |
0–1 |
1.00 (1.00–1.00) |
1–2 |
0.88 (0.69–1.11) |
2–3 |
0.94 (0.75–1.17) |
3–4 |
0.75 (0.60–0.92) |
4–6 |
0.74 (0.61–0.91) |
>6 |
0.84 (0.65–1.08) |
Boggs et al. 2010 (21) |
U.S. |
F |
30–69 |
12 |
46,906 |
3,671 |
Self-reported |
Caffeinated coffee |
|
Age, questionnaire cycle, energy intake, education, family history of diabetes, vigorous activity, smoking, glycemic index, cereal fiber, sugar-sweetened soft drinks, BMI, history of hypertension, and history of high cholesterol |
6 |
0e |
1.00 (1.00–1.00) |
1 cup/mo to |
|
<1 cup/day |
0.94 (0.86–1.04) |
1 |
0.90 (0.81–1.01) |
2–3 |
0.82 (0.72–0.93) |
≥4 |
0.83 (0.69–1.01) |
Decaf. coffee |
|
0e |
1.00 (1.00–1.00) |
1 cup/mo to |
|
<1 cup/day |
1.04 (0.93–1.16) |
1 |
1.07 (0.92–1.25) |
2–3 |
1.01 (0.83–1.24) |
≥4 |
1.10 (0.81–1.49 |
Sartorelli et al. 2010 (20) |
Europe |
F |
41–72 |
11 |
69,532 |
1,415 |
Confirmed self-report |
Total coffee |
|
Age, history of diabetes in ascendants, quartiles of physical activity level, quartiles of alcohol intake, educational level, hypercholesterolemia, hypertension, smoking, energyadjusted fiber and saturated fat, total energy without alcohol, menopausal status, hormone replacement therapy as a time-dependent variable, use of oral contraceptives at baseline, and timedependent BMI |
7 |
0 |
1.00 (1.00–1.00) |
≤1 |
1.04 (0.87–1.26) |
1.1–2.9 |
0.86 (0.73–1.02) |
≥3 |
0.73 (0.61–0.87) |
Caffeinated coffee |
|
0 |
1.00 (1.00–1.00) |
≤1 |
0.85 (0.74–0.97) |
>1 |
0.67 (0.57–0.78) |
Decaf. coffee |
|
0 |
1.00 (1.00–1.00) |
≤1 |
0.69 (0.51–0.93) |
>1 |
0.67 (0.47–0.95) |
Caffeineb |
|
48 |
1.00 (1.00–1.00) |
126 |
0.84 (0.72–0.96) |
209 |
0.77 (0.66–0.89) |
397 |
0.67 (0.58–0.78) |
Goto et al. 2011 (12) |
U.S. |
F |
Mean 60 |
10 |
718 |
359 |
Confirmed self-report |
Caffeinated coffee |
|
Age, race, duration of follow-up, time of blood draw, smoking status, physical activity, family history of diabetes, alcohol use, total calories, and BMI |
7 |
0 |
1.00 (1.00–1.00) |
≤1 |
0.92 (0.46–1.84) |
2–3 |
0.96 (0.48–1.94) |
≥4 |
0.71 (0.31–1.61) |
Decaf. coffee |
|
0 |
1.00 (1.00–1.00) |
≤1 |
1.31 (0.84–2.03) |
2–3 |
0.91 (0.42–2.00) |
≥4 |
0.92 (0.26–3.27) |
Caffeineb |
|
13 |
1.00 (1.00–1.00) |
140 |
1.53 (0.71–3.30) |
366 |
1.70 (0.79–3.62) |
656 |
1.32 (0.61–2.82) |
Hjellvik et al. 2011 (6) |
Europe |
Both |
40–45 |
5–20 |
362,045 |
9,886 |
Confirmed cases |
Total coffee |
|
Year of birth and, where relevant, sex, BMI, smoking, education, and physical activity |
7 |
<1 |
1.00 (1.00–1.00) |
1–4 |
0.84 (0.79–0.89) |
5–8 |
0.65 (0.61–0.70) |
>9 |
0.63 (0.58–0.69) |
Floegel et al. 2012 (8) |
Europe |
Both |
35–65 |
8.9 |
42,659 |
1,432 |
Confirmed self-report |
Caffeinated coffee |
|
Age, center, sex, smoking, alcohol intake, physical activity, education, employment, vitamin andmineral supplement use during past 4 wk, total energy intake, tea intake, decaf. coffee intake, BMI, waist-hip ratio, and prevalent hypertension |
7 |
<1 |
1.00 (1.00–1.00) |
1–2 |
0.89 (0.69–1.16) |
2–3 |
0.92 (0.76–1.13) |
3–4 |
0.82 (0.65–1.02) |
≥4 |
0.77 (0.63–0.94) |
Decaf. coffee |
|
<1 |
1.00 (1.00–1.00) |
1–2 |
0.97 (0.68–1.39) |
2–3 |
1.11 (0.84–1.48) |
3–4 |
0.70 (0.41–1.19) |
≥4 |
0.70 (0.46–1.06) |
Bhupathiraju et al. 2013 (19) |
U.S. |
Both |
M 40–75 F 30–55 |
M 22 F 24 |
39,059 |
2,865 |
Confirmed self-report |
Caffeinated coffee (men) |
|
Age; total caloric intake; family history of diabetes; alcohol consumption; smoking status; menopausal status; postmenopausal hormone use; intake of glycemic load, trans fat, polyunsaturated fatty acid, cereal fiber, and magnesium; BMI; and physical activity |
6 |
<1 |
1.00 (1.00–1.00) |
1–3 |
0.95 (0.88–1.03) |
4–5 |
0.92 (0.82–1.05) |
≥6 |
0.65 (0.49–0.85) |
Caffeinated coffee (women) |
|
<1 |
1.00 (1.00–1.00) |
1–3 |
0.91 (0.86–0.95) |
4–5 |
0.78 (0.72–0.85) |
≥6 |
0.65 (0.58–0.73) |
M 74,749 F 7,370 |
Decaf. coffee (men) |
|
0 |
1.00 (1.00–1.00) |
<1 |
0.92 (0.84–1.01) |
1–3 |
0.84 (0.75–0.93) |
≥4 |
0.84 (0.68–1.03) |
Decaf. coffee (women) |
|
0 |
1.00 (1.00–1.00) |
<1 |
0.95 (0.89–1.00) |
1–3 |
0.86 (0.81–0.92) |
≥4 |
0.73 (0.64–0.84 |
Doo et al. 2013 (18) |
U.S. |
Both |
45–75 |
14 |
75,140 |
8,582 |
Confirmed cases |
Total coffee (men) |
|
Age and adjusted for ethnicity, BMI, physical activity, education, history of hypertension, energy, alcohol intake, smoking status, sugared sodas, dietary fiber per 4,184 kJ, and processed meat per 4,184 kJ |
9 |
0 |
1.00 (1.00–1.00) |
<1 |
1.12 (1.01–1.24) |
1 |
1.06 (0.97–1.17) |
2 |
1.05 (0.95–1.16) |
≥3 |
0.95 (0.84–1.08) |
Total coffee (women) |
|
0 |
1.00 (1.00–1.00) |
<1 |
1.08 (0.98–1.19) |
1 |
0.96 (0.87–1.05) |
2 |
0.82 (0.74–0.91) |
≥3 |
0.69 (0.59–0.81) |
Caffeinated coffee (men) |
|
0 |
1.00 (1.00–1.00) |
<1 |
1.07 (0.98–1.18) |
1 |
1.02 (0.93–1.11) |
2 |
0.99 (0.91–1.09) |
≥3 |
0.86 (0.75–0.98) |
Caffeinated coffee (women) |
|
0 |
1.00 (1.00–1.00) |
<1 |
1.02 (0.94–1.12) |
1 |
0.93 (0.86–1.01) |
2 |
0.75 (0.68–0.83) |
≥3 |
0.65 (0.54–0.78) |
Decaf. coffee (men) |
|
0 |
1.00 (1.00–1.00) |
<1 |
1.08 (1.00–1.16) |
1 |
1.03 (0.93–1.15) |
≥2 |
1.07 (0.93–1.23) |
Decaf. coffee (women) |
|
0 |
1.00 (1.00–1.00) |
<1 |
1.07 (0.99–1.15) |
1 |
1.03 (0.92–1.14) |
≥2 |
0.85 (0.72–1.01) |